RESECTABLE SKIN LYMPHOEPITHELIAL CARCINOMA

Clinical trials for RESECTABLE SKIN LYMPHOEPITHELIAL CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new RESECTABLE SKIN LYMPHOEPITHELIAL CARCINOMA trials appear

Sign up with your email to follow new studies for RESECTABLE SKIN LYMPHOEPITHELIAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New hope for advanced skin cancer: boosting immune system before surgery

Disease control Recruiting now

This large, late-stage trial is testing if adding an immunotherapy drug (cemiplimab) before and after surgery works better than surgery alone for people with advanced, operable skin cancer. The goal is to see if this approach helps the body's immune system fight the cancer, reduc…

Matched conditions: RESECTABLE SKIN LYMPHOEPITHELIAL CARCINOMA

Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 20, 2026 14:48 UTC

RESECTABLE SKIN LYMPHOEPITHELIAL CARCINOMA

Get alerted when new RESECTABLE SKIN LYMPHOEPITHELIAL CARCINOMA trials appear

New hope for advanced skin cancer: boosting immune system before surgery